Publikacje w czasopismach z IF w 2011 (IF>1)

1. Ablewska U, Jankowski K, Rzewuska E, Liszewska-Pfejfer D, Hryniewiecki T.: A levels of endogenous gonadal hormones and their relationship with selected coronary artery disease risk factors among young women post myocardial infarction. Acta Biochim Pol. 2011; 58(3): 385-9. (IF=1.234; MNiSW=13).
   
   
2. Abramczuk E, Heretyk-Grabowska H, Grabowski M, Demkow M, Witkowski A, Konka M, Hryniewiecki T.: Rare complication after mitral valve replacement due to infective endocarditis. Med Sci Monit. 2011; 17(6): CQ1-CQ2. (IF=1.699; MNiSW=20).
   
   
3. Abramczuk E, Heretyk-Grabowska H, Grabowski M, Demkow M, Witkowski A, Konka M, Hryniewiecki T.: Rare complication after mitral valve replacement due to infective endocarditis (Part 2). Med Sci Monit. 2011; 17(7): CQ3-6. (IF=1.699; MNiSW=20).
   
   
4. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L, the APPRAISE-2 Investigators.: Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome. N Engl J Med. 2011; 365(8):699-708;(IF=53.486; MNiSW=40).
   
   
5. Biernacka EK, Hoffman P.: Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia. Europace. 2011; 13(1): 129-130; (IF=1.842; MNiSW=20).
   
   
6. Bilinska M, Nazar K.: Exercise Is Beneficial: But How and Why? Circ J. 2011; 75(4): 1012 (IF=3.225; MNiSW=27).
   
   
7. Ciszewski M, Pregowski J, Teresinska A, Karcz M, Kalinczuk L, Pracon R, Witkowski A.: Aspiration coronary thrombectomy for acute myocardial infarction increases myocardial salvage. Single center randomized study. Catheter Cardiovasc Interv. 2011; 78(4): 523-31; (IF=2.398; MNiSW=27).
   
   
8. Czerwinska K, Orłowska-Baranowska E, Witkowski A, Demkow M, Abramczuk E, Michałek P, Greszata L, Stoklosa P, Kuśmierski K, Kowal J, Stepinska J.: Transapical aortic valve implantation – a rescue procedure for patients with aortic stenosis and “porcelain aorta”. Arch Med Sci. 2011; 7(3): 528-532. (IF=1.199; MNiSW=20).
   
   
9. Demkow M, Biernacka EK, Spiewak M, Kowalski M, Siudalska H, Wolski P, Sondergaard L, Misko J, Hoffman P, Ruzyllo W.: Percutaneous pulmonary valve implantation preceded by routine prestenting with a bare metal stent. Catheter Cardiovasc Interv. 2011; 77(3): 381-389 (IF=2.398; MNiSW=27).
   
   
10. Dzielińska Z, Małek LA, Januszewicz A, Prejbisz A, Pręgowski J, Tyczyński P, Makowiecka-Cieśla M, Janas J, Demkow M, Rużyłło W.: Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes. Arch Med Sci. 2011; 7(6): 971-976. (IF=1.199; MNiSW=20)
    
    
11. Fidzianska A, Walczak E, Bekta P, Chojnowska L.: Are cardiomyocytes able to generate pre-amyloid peptides? Folia Neuropathol. 2011; 49(1): 64-70. (IF=1.222; MNiSW=13).
    
    
12. Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hufner M, Wohllk N, Opocher G, Dvorakova S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorlander C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wuster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP, and for the International RET Exon 10 Consortium.: Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat. 2011; 32(1): 51-58; (IF=5.956; MNiSW=32).
    
    
13. Gallanagh S, Castagno D, Wilson B, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Hoglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ, McMurray JJ.: Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II). Cardiovasc Drugs Ther. 2011; 25(1): 77-85 (IF=3.098; MNiSW=27).
    
    
14. Gasior M, Slonka G, Wilczek K, Gierlotka M, Ruzyllo W, Zembala M, Osadnik T, Dubiel J, Zdrojewski T, Kalarus Z, Polonski L.: Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes - PL-ACS). Am J Cardiol. 2011; 107(1): 30-36. (IF=3.681; MNiSW=32).
    
    
15. Grabowski M, Hryniewiecki T, Janas J, Stepinska J.: Clinically overt and silent cerebral embolism in the course of infective endocarditis. J Neurol. 2011; 258(6): 1133-1139; (IF=3.853; MNiSW=32).
    
    
16. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, for the ROADMAP Trial Investigators*.: Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes. N Engl J Med. 2011; 364(10): 907-17. (IF=53.486; MNiSW=40).
    
    
17. Hochman JS, Reynolds HR, Dzavik V, Buller CE, Ruzyllo W, Sadowski ZP, Maggioni AP, Carvalho AC, Rankin JM, White HD, Goldberg S, Forman SA, Mark DB, Lamas GA, for the Occluded Artery Trial Investigators.: Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction. Circulation. 2011; 124(21): 2320-2328;(IF=14.432; MNiSW=32).
    
    
18. Hoffman P, Dobrowolski P, Pregowski J, Kowalski M.: Anomalous origin of the right coronary artery from the pulmonary artery coexisting with aortopulmonary window and partial abnormal drainage of the pulmonary vein. Eur J Echocardiogr. 2011; 12(10): 803. (IF=2.117; MNiSW=20).
    
    
19. Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB.: Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the assessment of pexelizumab in acute myocardial infarction trial. Circ Cardiovasc Qual Outcomes. 2011; 4(2): 183-192. (IF=4.840).
    
    
20. Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL,Jr, Haller H.: Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study). J Hum Hypertens. 2011; 25(11): 679-685 (IF=2.176; MNiSW=27).
    
    
21. Jaworska-Wilczynska M, Abramczuk E, Hryniewiecki T.: Postcardiac injury syndrome. Med Sci Monit. 2011; 17(11): CQ13-14. (IF=1.699; MNiSW=20)
    
    
22. Juraszynski Z, Opolski MP, Kepka C.: Computed tomography for detection and postoperative imaging of the left anterior descending artery occlusion incompletely visualized by conventional angiography. Eur J Cardiothorac Surg. 2011; 40(1): e68. (IF=2.293; MNiSW=32).
    
    
23. Kadziela J, Witkowski A, Januszewicz A, Cedro K, Micha Owska I, Januszewicz M, Kabat M, Prejbisz A, Kali Czuk U, Ziele P, Michel-Rowicka K, Warcho E, Ru YOW.: Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve ? Relationship to angiography and ultrasonography. Blood Press. 2011; 20(4): 211-214. (IF=1.256; MNiSW=20).
    
    
24. Kalinczuk L, Lubiszewska B, Demkow M.: Normal chest radiograph and ground glass opacities on a thoracic computed tomographic scan in a patient with diffuse alveolar haemorrhage due to dual antiplatelet therapy prescribed after patent foramen ovale percutaneous device closure. Eur Heart J. 2011; 32(23): 2988. (IF=10.052; MNiSW=32).
    
    
25. Kepka C, Opolski MP, Juraszynski Z, Ruzyllo W.: Coronary Computed Tomography Angiography Without Catheter Angiography Before Bypass Surgery in a Patient With Diffuse Aortic Atherosclerosis. J Thorac Imaging. 2011; 26(2): W48-50; (IF=1.207; MNiSW=20).
    
    
26. Kepka C, Opolski MP, Kruk M, Michalowska I.: Dual-source computed tomography for detection and postoperative imaging of the malignant right coronary artery anomaly. Eur J Cardiothorac Surg. 2011; 39(6): 1075; (IF=2.293; MNiSW=32).
    
    
27. Kiliszek M, Franaszczyk M, Kozluk E, Lodzinski P, Piatkowska A, Broda G, Ploski R, Opolski G.: Association between Variants on Chromosome 4q25, 16q22 and 1q21 and Atrial Fibrillation in the Polish Population. PLoS One. 2011; 6(7): e21790. (IF=4.411).
    
    
28. Konopka A, Stepien-Wojno M, Marona M, Greszata L, Dyk W, Stepinska J.: A severe complication after ST-segment elevation myocardial infarction (Part 2). Med Sci Monit. 2011; 17(10): CQ9-12. (IF=1.699; MNiSW=20)
    
    
29. Konopka A, Szperl M, Piotrowski W, Roszczynko M, Stepinska J.: Influence of Renin-Angiotensin System Gene Polymorphisms on the Risk of ST-Segment-Elevation Myocardial Infarction and Association with Coronary Artery Disease Risk Factors. Mol Diagn Ther. 2011; 15(3): 167-176. (IF=2.561; MNiSW=20).
    
    
30. Kowalik E, Kowalski M, Hoffman P.: Is right ventricular myocardial deformation affected by degree of interatrial shunt in adults? Eur J Echocardiogr. 2011; 12(5): 400-405; (IF=2.117; MNiSW=20).
    
    
31. Kowalik E, Kowalski M, Rozanski J, Kusmierczyk M, Hoffman P.: The Impact of Pulmonary Regurgitation on Right Ventricular Regional Myocardial Function: An Echocardiographic Study in Adults after Total Repair of Tetralogy of Fallot. J Am Soc Echocardiogr. 2011; 24(11): 1199-204. (IF=3.520; MNiSW=27).
    
    
32. Kukuła K, Chojnowska L, Dąbrowski M, Witkowski A, Chmielak Z, Skwarek M, Kądziela J, Teresińska A, Małecki M, Janik P, Lewandowski Z, Kłopotowski M, Wnuk J, Rużyłło W.: Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Am Heart J. 2011; 161(3):581-589; (IF=5.052; MNiSW=32).
    
    
33. Lipczynska M, Szymanski P, Klisiewicz A, Hoffman P.: Hand-carried echocardiography in heart failure and heart failure risk population: a community based prospective study. J Am Soc Echocardiogr. 2011; 24(2): 125-131. (IF=3.520; MNiSW=27).
    
    
34. Lugowska A, Poninska J, Krajewski P, Broda G, Ploski R.: Population Carrier Rates of Pathogenic ARSA Gene Mutations: Is Metachromatic Leukodystrophy Underdiagnosed? PLoS One. 2011; 6(6): e20218. (IF=4.411).
    
    
35. Malek LA, Labib S, Mazurkiewicz L, Saj M, Ploski R, Tesson F, Bilinska ZT.: A new c.1621 C>G, p.R541G lamin A/C mutation in a family with DCM and regional wall motion abnormalities (akinesis/dyskinesis): genotype-phenotype correlation. J Hum Genet. 2011; 56(1): 83-86. (IF=2.496; MNiSW=20).
    
    
36. Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid JP, Anker SD, Solal AC, Filippatos GS, Hoes AW, Gielen S, Giannuzzi P, Ponikowski PP.: Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011; 13(4): 347-357. (IF=4.512; MNiSW=32).
    
    
37. Pracon R, Kruk M, Kepka C, Pregowski J, Opolski MP, Dzielinska Z,Michalowska I, Chmielak Z, Demkow M, Ruzyllo W.: Epicardial Adipose Tissue Radiodensity Is Independently Related to Coronary Atherosclerosis. Circ J. 2011; 75(2): 391-397. (IF=3.225; MNiSW=27).
    
    
38. Pregowski J, Kepka C, Kalinczuk L, Kruk M, Mintz GS, Ciszewski A, Chmielak Z, Ciszewski M, Wolny R, Szubielski M, Tyczynski P, Witkowski A.: Comparison of Intravascular Ultrasound, Quantitative Coronary Angiography, and Dual-Source 64-Slice Computed Tomography in the Preprocedural Assessment of Significant Saphenous Vein Graft Lesions. Am J Cardiol. 2011; 107(10): 1453-1459; (IF=3.681; MNiSW=32).
    
    
39. Pregowski J, Kepka C, Kruk M, Mintz GS, Kalinczuk L, Ciszewski M, Ciszewski A, Wolny R, Szubielski M, Chmielak Z, Demkow M, Norwa-Otto B, Opolski M, Tyczynski P, Ruzyllo W, Witkowski A.: Comparison of Usefulness of Percutaneous Coronary Intervention Guided by Angiography plus Computed Tomography Versus Angiography Alone Using Intravascular Ultrasound End Points. Am J Cardiol. 2011; 108(12): 1728-34. (IF=3.681; MNiSW=32)
    
    
40. Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A.: Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011; 29(11): 2049-2060.;(IF=3.980; MNiSW=32).
    
    
41. Sobczyk-Kopciol A, Broda G, Wojnar M, Kurjata P, Jakubczyk A, Klimkiewicz A, Ploski R.: Inverse association of the obesity predisposing FTO rs9939609 genotype with alcohol consumption and risk for alcohol dependence. Addiction. 2011; 106(4): 739-748. (IF=4.145; MNiSW=32).
    
    
42. Spiewak M, Biernacka EK, Malek LA, Misko J, Kowalski M, Milosz B, Petryka J, Zabicka M, Ruzyllo W.: Quantitative assessment of pulmonary regurgitation in patients with and without right ventricular tract obstruction. Eur J Radiol. 2011; 80(2): e 164-8; (IF=2.941; MNiSW=27).
    
    
43. Spiewak M, Biernacka EK, Malek LA, Petryka J, Kowalski M, Milosz B, Zabicka M, Misko J, Ruzyllo W.: Right ventricular outflow tract obstruction as a confounding factor in the assessment of the impact of pulmonary regurgitation on the right ventricular size and function in patients after repair of tetralogy of fallot. J Magn Reson Imaging. 2011; 33(5): 1040-1046. (IF=2.749; MNiSW=32).
    
    
44. Stachurska E, Loboda A, Niderla-Bielinska J, Szperl M, Juszynski M, Jozkowicz A, Dulak J, Ratajska A.: Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid. Acta Biochim Pol. 2011; 58(1): 19-29. (IF=1.234; MNiSW=13).
    
    
45. Staessen JA, Thijs L, Stolarz-Skrzypek K, Bachieri A, Barton J, Degli Espositi E, de Leeuw PW, Dluzniewski M, Glorioso N, Januszewicz A, Manunta P, Milyagin V, Nikitin Y, Soucek M, Lanzani C, Citterio L, Timio M, Tykarski A, Ferrari P, Valentini G, Kawecka-Jaszcz K, Bianchi G.: Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase 2 dose-finding study of rostafuroxin. Trials. 2011; 12(1): 13. (IF=2.080; MNiSW=20).
    
    
46. Stepien-Wojno M, Konopka A, Marona M, Greszata L, Dyk W, Stepinska J.: A severe complication after ST-segment elevation myocardial infarction (Part 1). Med Sci Monit. 2011; 17(9): CQ7-8. (IF=1.699; MNiSW=20).
    
    
47. Szwench E, Peczkowska M, Marczewski K, Klisiewicz A, Michalowska I, Ciuba I, Januszewicz M, Prejbisz A, Hoffman P, Januszewicz A.: Phaeochromocytoma in a 86-year-old patient presenting with reversible myocardial dysfunction. Blood Press. 2011; 20(6): 383-6; (IF=1.256; MNiSW=20).
    
    
48. Szymanski P, Klisiewicz A, Hoffman P.: ARVC/D Task Force Imaging Criteria It Is Difficult to Get Along With the Guidelines. JACC Cardiovasc Imaging. 2011; 4(6): 686. (IF=5.528).
    
    
49. Szymanski P, Klisiewicz A, Lubiszewska B, Lipczynska M, Kowalski M, Janas J, Hoffman P.: Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension. Int J Cardiol. 2011; 147(3): 366-370 (IF=6.802 MNiSW=27).
    
    
50. Szyndler A, Kucharska W, Dubiela-Dabrowska A, Olszanecka A, Widecka J, Baczkiewicz M, Widecka K, Galas G, Chlebinska I, Sakiewicz W, Gaciong Z, Widecka K, Januszewicz A, Kawecka-Jaszcz K, Narkiewicz K, The Polish Hypertension Registry.: SCORE model underestimates cardiovascular risk in hypertensive patients: Results of the Polish Hypertension Registry. Blood Press. 2011; 20(6): 342-347. (IF=1.256; MNiSW=20).
    
    
51. Udelson JE, Pearte CA, Kimmelstiel CD, Kruk M, Kufera JA, Forman SA, Teresinska A, Bychowiec B, Marin-Neto JA, Hochtl T, Cohen EA, Caramori P, Busz-Papiez B, Adlbrecht C, Sadowski ZP, Ruzyllo W, Kinan DJ, Lamas GA, Hochman JS.: The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone. Am Heart J. 2011; 161(3): 611-621. (IF=5.052; MNiSW=32).
    
    
52. Van Gelder IC, Haegeli LM, Brandes A, Heidbuchel H, Aliot E, Kautzner J, Szumowski L, Mont L, Morgan J, Willems S, Themistoclakis S, Gulizia M, Elvan A, Smit MD, Kirchhof P.: Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace. 2011; 13(11): 1517-25. (IF=1.842; MNiSW=20).
    
    
53. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, the STICH Investigators.: Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med. 2011; 364(17): 1607-1616; (IF=53.486; MNiSW=40).
    
    
54. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A.: Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea. Hypertension. 2011; 58(4): 559-675; (IF=6.908; MNiSW=32).
    
    
55. Wolkanin-Bartnik J, Pogorzelska H, Bartnik A.: Patient Education and Quality of Home-Based Rehabilitation in Patients Older Than 60 Years After Acute Myocardial Infarction. J Cardiopulm Rehabil Prev. 2011; 31(4): 249-53. (IF=1.415).
    
    
56. Woodward M, Patel A, Zoungas S, Liu L, Pan C, Poulter N, Januszewicz A, Tandon N, Joshi P, Heller S, Neal B, Chalmers J.: Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial. Diabetes Care. 2011; 34(12): 2491-5; (IF=7.141; MNiSW=32).